What's New for BTK Inhibitors in B-Cell Malignancies? A Winter Hematology Conference Update

episode

Keeping Current CME not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

recent transcribed audio

280926 money diary 44 min · 27 Sep 2026 · She's On The Money

AI safety fears hit Washington 3 min · 27 Sep 2026 · Wall Street Breakfast

Did David do something BAD? 10 min · 27 Sep 2026 · The David Pakman Show

27/09/2026 14 min · 27 Sep 2026 · The Archers

2PM ET 09/27/2026 Newscast 3 min · 27 Sep 2026 · Fox News Hourly Update

John Small: Commerce Commission Chair on clampdown of cartel behaviour and bid rigging 3 min · 27 Sep 2026 · The Mike Hosking Breakfast

Report any issue

Source

Recorded05 Jan 2022

Publisherkeepingcurrentcme.libsyn.com ↗

Handlerec:4299960

Show notes

Dr Woyach discusses new clinical data with BTK inhibitors in both chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/965742?src=mkm_podcast_addon_965742

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related